You are here

  • Home
  • Archive
  • Volume 21, Issue 6
  • Possible Use of CA-125 Level Normalization After the Third Chemotherapy Cycle in Deciding on Chemotherapy Regimen in Patients With Epithelial Ovarian Cancer: Brief Report

Article info

Article menu
Download PDFPDF
Ovarian Cancer
Possible Use of CA-125 Level Normalization After the Third Chemotherapy Cycle in Deciding on Chemotherapy Regimen in Patients With Epithelial Ovarian Cancer: Brief Report

Authors

  1. Address correspondence and reprint requests to Paniti Sukumvanich, MD, Division of Gynecologic Oncology, Magee-Womens Hospital of the University of Pittsburgh Medical Center, 300 Halket St, Pittsburgh, PA 15213. E-mail: psukumvanich{at}upmc.edu.

Citation

Skaznik-Wikiel ME, Sukumvanich P, Beriwal S, et al
Possible Use of CA-125 Level Normalization After the Third Chemotherapy Cycle in Deciding on Chemotherapy Regimen in Patients With Epithelial Ovarian Cancer: Brief Report
International Journal of Gynecologic Cancer 2011;21:1013-1017.

Publication history

  • Received December 30, 2010
  • First published August 1, 2011.
Online issue publication 
August 01, 2011

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright © 2011 by IGCS and ESGO